Schizoaffective Disorders Active Not Recruiting Phase 4 Trials for Exenatide (DB01276)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02417142Exenatide Weekly Injections as an Adjunctive Treatment in Patients With SchizophreniaTreatment